Glioblastoma: current status, emerging targets, and recent advances

A Thakur, C Faujdar, R Sharma, S Sharma… - Journal of Medicinal …, 2022 - ACS Publications
Glioblastoma (GBM) is a highly malignant brain tumor characterized by a heterogeneous
population of genetically unstable and highly infiltrative cells that are resistant to …

Neuropharmacological effect of risperidone: From chemistry to medicine

AA Bhat, G Gupta, O Afzal, I Kazmi, FA Al-Abbasi… - Chemico-biological …, 2023 - Elsevier
As the second-oldest atypical antipsychotic, risperidone has a long history of off-label usage
for treating behavioural and psychological signs and symptoms of dementia (BPSD), such …

Intranasal delivery of Naloxone-loaded solid lipid nanoparticles as a promising simple and non-invasive approach for the management of opioid overdose

N Hasan, M Imran, P Kesharwani, K Khanna… - International journal of …, 2021 - Elsevier
Naloxone is an opioid receptor antagonist that can eradicate all pre-indications of the toxicity
and inverse the opioid overdose. However, oral administration of naloxone offers limitations …

[HTML][HTML] Glioblastoma preclinical models: Strengths and weaknesses

V Pasupuleti, L Vora, R Prasad… - … et Biophysica Acta (BBA …, 2024 - Elsevier
Glioblastoma multiforme is a highly malignant brain tumor with significant intra-and
intertumoral heterogeneity known for its aggressive nature and poor prognosis. The complex …

Lichen secondary metabolites inhibit the Wnt/β-catenin pathway in glioblastoma cells and improve the anticancer effects of Temozolomide

A Majchrzak-Celińska, R Kleszcz, E Studzińska-Sroka… - Cells, 2022 - mdpi.com
Lichens are a source of secondary metabolites with significant pharmacological potential.
Data regarding their possible application in glioblastoma (GBM) treatment are, however …

Prognostic biomarker prediction for glioma induced by heavy metals and their mixtures: an in-silico study

HD Nguyen - Toxicology and Applied Pharmacology, 2023 - Elsevier
Although there is an association between heavy metals and glioma, the molecular
mechanisms involved in glioma development remain unclear. Therefore, this study aimed to …

Role of scaffold proteins in the heterogeneity of glioblastoma

VJ Iyer, JE Donahue, MA Osman - Cell Communication and Signaling, 2024 - Springer
Glioblastoma (GB) is a highly heterogeneous type of incurable brain cancer with a low
survival rate. Intensive ongoing research has identified several potential targets; however …

A narrative review on the biology of piezo1 with platelet-rich plasma in cardiac cell regeneration

KS Alharbi, WH Almalki, SI Alzarea, I Kazmi… - Chemico-Biological …, 2022 - Elsevier
Cardiomyocyte regeneration following cardiac damage is challenging to study because of
the inflammatory process, the multiplication of cells in the stroma, and the creation of scar …

[PDF][PDF] G-García

AC Fuentes-Fayos, JM Pérez-Gómez - Int. J. Mol. Sci, 2022 - academia.edu
Glioblastoma (GBM) is the most malignant and lethal brain tumor. Current standard
treatment consists of surgery followed by radiotherapy/chemotherapy; however, this is only a …

A multistep in silico approach identifies potential glioblastoma drug candidates via inclusive molecular targeting of glioblastoma stem cells

N Dogra, P Singh, A Kumar - Molecular Neurobiology, 2024 - Springer
Glioblastoma (GBM) is the highest grade of glioma for which no effective therapy is currently
available. Despite extensive research in diagnosis and therapy, there has been no …